No additional drugs(control Group)
OtherNo intervention
NCT Number: NCT07115810
The goal of this observational study is to compare the clinical outcomes, molecular features, and immune profiles of patients with synchronous and metachronous distant metastases in Saudi cohort with well characterized differentiated thyroid cancer. The main question it aims to answer is whether timing of metastasis is associated with distinct prognostic or biological behavior in differentiated thyroid cancer from a large Middle Eastern cohort
Looking for future studies?
Notify MeOnly the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No intervention
Time frame: 5 years
Time frame: 5 years
King Faisal Specialist Hospital & Research Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03986437
Differentiated Thyroid Cancer
Toulouse, France
View Trial DetailsNCT04321954
Advanced Cancer, Differentiated Thyroid Cancer
Boston, Massachusetts, United States
View Trial DetailsNCT05660954
Differentiated Thyroid Cancer, Endocrine System Diseases
A Coruña, Spain
View Trial DetailsNCT05078853
Adenocarcinoma, Adenocarcinoma, Papillary
Ashkelon, Israel
View Trial Details